Rapid Micro Biosystems

Rapid Micro Biosystems

Life Sciences Tools & Services
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

$44.8M

Market Cap • 10/9/2026

2006

(20 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

2,5

P/S

1,3

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,4

EPS

—

Market Cap

Market Cap

44,8M

EV

48,5M

EV/Revenue

1,4

EV/EBITDA

-1

EV/EBIT

-1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-23%

Total Yield

-23%

Payout

0%

Retained Earnings

-549,6M

Profitability

Gross Margin

5,5%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

38,2%

Capex/Revenue

1%

Capex/D&A

11,3%

Capex/OCF

-0,8%

SBC/OCF

—

% PPE

20,1%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

10,2%

CAGR Op. Income 5Y

5,6%

CAGR Net Income 5Y

-1%

CAGR EPS 5Y

-61%

CAGR OCF 5Y

1,7%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

2,5

Quick Ratio

1,4

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium